As Thanksgiving approaches, it's a time to reflect on what we’re grateful for and how we can truly appreciate those blessings. From family and friends to the incredible BioSurfaces team and the support of our partners, gratitude reminds us of the foundation that keeps us moving forward. Take a moment this week to reflect on what you're thankful for and visit our latest blog to hear our thoughts. Wishing you and your loved ones a very Happy Thanksgiving! Read more: https://lnkd.in/e6vscJud #Thanksgiving2024 #Gratitude #ThankfulHeart #BioSurfaces #TeamworkMatters
BioSurfaces, LLC
Nanotechnology Research
Ashland, Massachusetts 1,060 followers
Nanomaterial Solutions
About us
BioSurfaces, based in Ashland, Massachusetts, is a life science company with deep leadership and a diverse team of specialists. The company’s proprietary electrospinning technology known as Bio-Spun™ creates product solutions by engineering biology with synthetic cellular matrices for applications ranging from IVRT and delivery of bio-active therapeutics to medical devices and consumer health products. These materials can be made to form a variety of unusual and difficult-to-manufacture shapes while also demonstrating improved biocompatibility over other textile-based materials. The BioSurfaces manufacturing process also allows the incorporation of drugs or other bioactive agents directly into the nanofibers for localized release. BioSurfaces’ technology is validated by leading organizations in pharmaceuticals, medical devices, life sciences, and consumer products.
- Website
-
https://www.biosurfaces.us/
External link for BioSurfaces, LLC
- Industry
- Nanotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Ashland, Massachusetts
- Type
- Privately Held
- Founded
- 2003
Locations
-
Primary
200 Homer Avenue
Unit 1P
Ashland, Massachusetts 01721, US
Employees at BioSurfaces, LLC
Updates
-
Exciting News! BioSurfaces has been awarded a $2.06M grant from the Bill & Melinda Gates Foundation to advance the Bio-Spun™ Cell Chamber (BSCC)—an innovative device for long-term delivery of biotherapeutics to treat chronic illnesses. This game-changing technology addresses challenges like fibrosis, immune rejection, and therapy inconsistency in underserved regions. With proven potential to improve outcomes for diseases like diabetes and liver disease, the BSCC could revolutionize cell-based therapeutics worldwide. Learn more: https://lnkd.in/e2kRkjis #Innovation #Healthcare #Biotechnology #GlobalHealth #BioSpun #Grant #GatesFoundation
-
We're thrilled to announce that Dr. Patrick Hayden's abstract has been accepted for a poster presentation at the upcoming HIRN 10-Year Symposium: "Changing the Course of Type 1 Diabetes" in January 2025! This prestigious event will bring together leading minds in diabetes research to discuss advancements and innovations in the field. Dr. Hayden will showcase BioSurfaces' cutting-edge work and its potential to transform Type 1 Diabetes treatment. Stay tuned for updates on the poster session date and details. Let’s work together toward a future where Type 1 Diabetes is no longer a life-defining condition! #HIRN10YearSymposium #Type1Diabetes #DiabetesResearch #Innovation #BioSurfaces #PosterPresentation #HealthcareInnovation Picture Source: https://lnkd.in/e275jSNc
-
Throughout our country's history there have been 46 different presidents. During the span of some these administrations, the medical field has continued using materials like silicone, polyethylene, and titanium for medical devices—a practice that dates back to the 1950s and 1960s. However, these materials often fall short in long-term applications due to issues like poor integration with surrounding tissues, limited flexibility, and high rates of rejection or failure. #FactualFriday At BioSurfaces, we believe the next generation of medical devices can benefit from our Bio-Spun™ scaffold, a groundbreaking material designed for superior integration and adaptability. Unlike traditional materials, Bio-Spun™ provides an optimal environment for cellular attachment and growth, greatly reducing the likelihood of rejection. Its customizable structure allows for various configurations and functions within different biological environments, making it an ideal choice for advanced in vivo applications. #2024Election #NextGen #MedicalDevice #Breaththroughs #TissueIntegration Picture Credit: https://lnkd.in/eHWBik2p
-
Introducing The Spin Cycle—your new monthly source for insights and updates from BioSurfaces! Each month, we’ll rotate in fresh information on advancements like our 100% animal-free Bio-Spun™ Scaffolds, engineered for superior reliability in tissue models. Stay tuned to discover innovative solutions that drive research and in vivo success! https://lnkd.in/eq9y7cNC #TheSpinCycle #BioSpun #3DCellCulture #AnimalFree #CellTherapy #Innovation #Biotech #Research
-
Dr. Jayashree Chakravarty recently presented our innovative Bio-Spun™ Cell Chamber (BSCC) at the IPITA conference, showcasing its unique ability to promote tissue integration, reduce fibrosis, and provide immune protection. This tri-layer electrospun device is optimized for encapsulating human pancreatic islets, aiming to support long-term viability and glucose-responsive insulin secretion without immunosuppression. Explore the full poster on our website to learn more about this promising solution for cell-based therapies in Type 1 Diabetes. https://lnkd.in/ebseQAu6 #BioSpun #CellTherapy #T1D #DiabetesResearch #TissueEngineering #RegenerativeMedicine #IPITA #MedicalInnovation #FibrosisReduction
-
Excited to announce Dr. Jayashree Chakravarty will present our innovative Bio-Spun™ Cell Chamber at #iPITA2024 in Boston! Her poster shows promising data on this device’s potential to support Type 1 diabetes treatment by promoting tissue integration and minimizing immune response. Check it out next week, or find it on our site soon! https://lnkd.in/eDbJiS7Q #Biotech #DiabetesResearch #NextGenTech #Innovation
-
John Arderne (1307–1392), an English surgeon and one of the pioneers of surgery, is known for developing treatments for various conditions, including "Fistula in Ano," a painful abnormal passage between the rectum and the skin around the anus. His surgical techniques and the use of anesthetics, such as opium and hemlock, were groundbreaking for his time. Today, innovations like the Bio-Spun™ Fistula Plug continue the tradition of advanced treatments for such conditions, offering modern, biocompatible solutions. Click below to learn more about the Bio-Spun™ Fistula Plug. https://lnkd.in/dfdneW3V #MedicalInnovation #SurgicalPioneer #FistulaTreatment #BioSpunTechnology #ModernMedicine (Picture below of medical equipment that was used during Arderne's time)
-
Discover how a Quality Management System (QMS) ensures consistent, reliable products in the manufacturing world. Learn how companies like BioSurfaces streamline their processes using electronic QMS platforms like Greenlight Guru to meet stringent standards and maintain quality. Read the full blog to explore the benefits and implementation strategies! https://lnkd.in/edy2m-3F #QualityManagement #QMS #Manufacturing #MedicalDevices #ProductReliability
-
BioSurfaces’ In Vitro Research Tools (IVRT) platform is currently in the early stage of the product adoption curve, targeting innovators and early adopters in bioengineering and research. Our Bio-Spun™ scaffold is the first scaffold proven in vivo (pre-clinical) to demonstrate material capability for cell integration, it offers groundbreaking potential for research. By engaging with early users, BioSurfaces is refining its tools and gathering valuable feedback to ensure future success. The goal is to continue pushing the platform forward and, over time, expand to broader market adoption, eventually establishing it as the industry standard for in vitro research. For more information on our IVRT platform go check out the posters we have presented at conferences using the link below. https://lnkd.in/e8uWx5nA #InnovativeResearch #InVitroSuccess #BroaderAdoption #IndustryStandard #CellIntegration